Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mead Johnson Nutritionals Enfamil formula posts third quarter 6% rise to $165 mil..

This article was originally published in The Tan Sheet

Executive Summary

BRISTOL-MYERS' MEAD JOHNSON NUTRITIONALS SALES RISE 10% TO $443 MIL. in the third quarter, Bristol- Myers Squibb reported Oct. 22. Excluding the effects of foreign exchange, Mead Johnson would have posted an 11% sales gain, BMS noted. Sales of nutritionals were led by Enfamil, the firm's best-selling formula, which had revenues of $165 mil. in the third quarter, an increase of 6% from the year-earlier period.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts